Page 152 - วารสารกรมการแพทย์แผนไทยฯ ปีที่ 16 ฉบับที่ 1

142

®
20/30-2 ph 20/30-1 μ“´â“¬ 20/20-3, ocular pres- Õ¬à“ß §◊Õ Brimonidine eye drop ·≈– Lumigan
sure μ“¢«“ 11.2 mmHg μ“´â“¬ 12 mmHg eye drop ®“°°“√μ√«®§√—Èß·√° ‡¡◊ËÕ«—π∑’Ë 2 °—𬓬π
®
§«“¡¥—πμ“≈¥≈ߥ’ ∂Õπ Diamox §√—Èß≈– 1/2 ‡¡Á¥ 2558 æ∫«à“ V.A. Hm ∑—Èß 2 μ“, ocular pressure
× «—π≈– 2 §√—Èß μ“¢«“ 9.4 mmHg μ“´â“¬ 9.2 mmHg fundus
«—π∑’Ë 24 ¡‘∂ÿπ“¬π 2558: μ√«® V.A. μ“¢«“ examination æ∫«à“ optic disc ¡’ pale and full
20/30+2 ph 20/20-3 μ“´â“¬ 20/20-2, ocular pres- cupping ∑—Èß 2 μ“ ‰¥â√—∫°“√«‘π‘®©—¬‡ªìπ blindness

sure μ“¢«“ 12.7 mmHg μ“´â“¬ 11.9 mmHg from advanced POAG ‡√‘Ë¡°“√√—°…“¥â«¬ PPT +
§«“¡¥—πμ“ control ‰¥â¥’¥â«¬ PPT + 2% vitamin ·≈–∂Õ𬓠Lumigané eye drop

Isoptocarpine eye drop «—π≈– 2 §√—Èß∑’Ëμ“∑—Èß 2 «—π∑’Ë 30 °—𬓬π 2558: μ√«® V.A. Hm ∑—Èß
¢â“ß 2 μ“, ocular pressure μ“¢«“ 11.1 mmHg μ“
«—π∑’Ë 8 °√°Æ“§¡ 2558: μ√«® V.A. μ“¢«“ ´â“¬ 9.3 mmHg §«“¡¥—πμ“ control ‰¥â¥’¥â«¬ PPT

20/20-2 μ“´â“¬ 20/20-1, ocular pressure μ“¢«“ ®÷ßæ‘®“√≥“∂Õπ Brimonidine eye drop ·≈–‡√‘Ë¡
12.4 mmHg μ“´â“¬ 10.5 mmHg §«“¡¥—πμ“ con- „Àâ baby aspirin §√—Èß≈– 1 ‡¡Á¥ «—π≈– 1 §√—Èß
trol ‰¥â¥’¥â«¬ PPT + 2% Isoptocarpine eye drop «—π∑’Ë 9 惻®‘°“¬π 2558: μ√«® V.A. Hm

«—π≈– 2 §√—Èß∑’Ëμ“∑—Èß 2 ¢â“ß ∑—Èß 2 μ“, ocular pressure μ“¢«“ 10.4 mmHg
«—π∑’Ë 22 °√°Æ“§¡ 2558: μ√«® V.A. μ“¢«“ μ“´â“¬ 13.3 mmHg §«“¡¥—π쓬—ß control ‰¥â¥’
20/20 μ“´â“¬ 20/20, ocular pressure μ“¢«“ 12.7 ¥â«¬ PPT (∂Õπ¬“≈¥§«“¡¥—π≈Ÿ°μ“À¡¥·≈â«)

mmHg μ“´â“¬ 11.5 mmHg §«“¡¥—πμ“ control «—π∑’Ë 4 ¡°√“§¡ 2559: μ√«® V.A. μ“¢«“ Hm
‰¥â¥’¥â«¬ PPT + 2% Isoptocarpine eye drop «—π≈– μ“´â“¬ Fc 3 øÿμ, ocular pressure μ“¢«“ 8.8

2 §√—Èß∑’Ëμ“∑—Èß 2 ¢â“ß steroid ‰¥â tail off ·≈–∂Õπ mmHg μ“´â“¬ 7.7 mmHg §«“¡¥—π쓬—ß control
‰ª·≈â« ‡À≈◊Õ‡æ’¬ß baby aspirin «—π≈– 1 ‡¡Á¥ ‰¥â¥’¥â«¬ PPT
«—π∑’Ë 22 ‡¡…“¬π 2559: μ√«® follow up «—π∑’Ë 7 ¡’π“§¡ 2559: μ√«® V.A. μ“¢«“ Hm

§√—Èß ÿ¥∑⓬ V.A. μ“¢«“ 20/20-1 μ“´â“¬ 20/20, μ“´â“¬ 20/50-2 °“√¡Õ߇ÀÁπ√–¥—∫π’È ∑”„À⺟âªÉ«¬
ocular pressure μ“¢«“ 11.1 mm.Hg. μ“´â“¬ 12.6 °≈—∫‰ª„™â™’«‘μ‰¥âª°μ‘ ocular pressure μ“¢«“ 8.4

mm.Hg. §«“¡¥—πμ“ control ‰¥â¥’¥â«¬ PPT + 2% mmHg μ“´â“¬ 7.3 mmHg §«“¡¥—π쓬—ß control
Isoptocarpine eye drop «—π≈– 1 §√—Èß∑’Ëμ“∑—Èß 2 ‰¥â¥’¥â«¬ PPT
¢â“ß + baby aspirin «—π≈– 1 ‡¡Á¥ «—π‡«âπ«—π «—π∑’Ë 5 情¿“§¡ 2559: μ√«® follow up

√“¬∑’Ë 3 ºŸâªÉ«¬À≠‘߉∑¬ Õ“¬ÿ 59 ªï ¿Ÿ¡‘≈”‡π“ §√—Èß ÿ¥∑⓬ V.A. μ“¢«“ Hm μ“´â“¬ 20/50+2, ocu-
Õ¬Ÿà∑’Ë ‡¢μ∑ÿàߧ√ÿ °√ÿ߇∑æ¡À“π§√ ¡’ª√–«—μ‘μ√«®æ∫ lar pressure μ“¢«“ 8.4 mmHg μ“´â“¬ 7.3 mmHg
μâÕÀ‘π∑—Èß 2 μ“¡“ 1 ªï √—∫°“√√—°…“¥â«¬¬“À¬Õ¥μ“ §«“¡¥—π쓬—ß control ‰¥â¥’¥â«¬ PPT ·≈–√—∫

¡“Õ¬à“ßμàÕ‡π◊ËÕß ª√–¡“≥ 3 ‡¥◊Õπ°àÕπ¡“‚√ß欓∫“≈ ª√–∑“𬓠baby aspirin §√—Èß≈– 1 ‡¡Á¥ «—π≈– 1
μ“∑—Èß 2 ¢â“ߧàÕ¬ Ê ∫Õ¥ ·¡â®–„™â¬“À¬Õ¥μ“Õ¬Ÿà 2 §√—Èß